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a b s t r a c t
The association of sarcoidosis with multiple myeloma is not well known. Including this case report, 12 cases
of patients with both sarcoidosis and multiple myeloma have been reported in the literature. The skeletal
lesions of both conditions have many clinical and radiological similarities, and unless clinicians are aware of
the association and the possibility of dual pathologies, the diagnosis of multiple myeloma in patients known
with sarcoidosis may be missed. We present a case of a patient known with longstanding sarcoidosis who
was found to have multiple lesions on magnetic resonance imaging (MRI) involving the pelvis and both
proximal femurs. Histological analysis revealed the presence of both non-necrotising granulomas consistent
with sarcoidosis, and sheets of plasma cells consistent with a plasma cell neoplasm.
& 2014 Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Case presentation
A 50 year old female machinist presented to our general
orthopaedic outpatients' department with a 5 month history of
right groin and buttock pain of spontaneous onset. She had a
background history of hypertension and biopsy-proven sarcoido-
sis. The pain radiated to the right knee and had progressively
worsened over the preceding month. She had not experienced any
constitutional symptoms, had no previous malignancies, and had
been on a daily dose of 20 mg prednisone and 150 mg azathiopr-
ine for 4 years as part of her treatment for sarcoidosis.
Examination revealed an antalgic gait with a painful and stiff
right hip. The pain was most severe in ﬂexion and internal rotation.
An anteroposterior (AP) radiograph of the pelvis and lateral
radiograph of the right hip demonstrated moderate degenerative
changes of both hips (Figs. 1 and 2).
A provisional differential diagnosis of early avascular necrosis
(AVN) or femoroacetabular impingement (FAI) was made. Renal
function and calcium, magnesium and phosphate (CMP) levels
were normal, C-reactive protein was 8.5 mg/l and the erythrocyte
sedimentation rate was 40 mm/h. An MRI revealed no evidence of
AVN, with areas of intermediate to high signal in the right femoral
head and neck, as well as the left femur and pelvis (Figs. 3 and 4).
The MRI ﬁndings were in keeping with sarcoidosis. Further clinical
work up was recommended to exclude other causes such as
metastatic lesions or myeloma if clinically indicated.
By this time the patient's symptoms had continued to progress,
and a second AP pelvis X-ray (Fig. 5) revealed a lytic lesion in the
inferior neck of the right femur with a Mirels' score of 11 [1]. After
consultation with both the musculoskeletal tumour and arthro-
plasty units, it was decided to perform a biopsy of the femoral
head/neck and total hip replacement as a single stage procedure.
Uncemented acetabular and femoral components were used, with
a ceramic-on ceramic bearing surface. Macroscopic examination of
the excised femoral head conﬁrmed a 1713 mm2 lytic lesion in the
inferior neck. Histological analysis of the femoral head showed
hypercellular bone marrow with diffuse replacement of marrow
spaces by a population of mature plasma cells. Occasional plasma-
blasts and multinucleate forms were present (Figs. 6 and 7).
Immunohistochemistry demonstrated Lambda light chain restriction
(Fig. 8). In addition, scattered non-necrotising granulomas consistent
with sarcoidosis were present (Figs. 6 and 7). Special stains for acid-
fast bacilli and fungal organisms were negative.
Bone marrow aspiration, biopsy and serum protein electrophoresis
conﬁrmed the diagnosis of multiple myeloma (Fig. 9). The patient was
referred to the department of haematology, where treatment with
high dose dexamethasone and cyclophosphamide was started.
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At most recent follow-up 5 months post surgery the patient
had an asymptomatic right hip with no change in component
position (Fig. 10), and no progression of the lesions in her left hip
and pelvis.
The patient's clinical and biochemical response to the myeloma
treatment has been good, with a drop in the IgG Lambda monoclonal
peak from 80 g/l to 30 g/l. Autologous haemopoetic stem cell
transplant is planned after maximal response has been achieved
with cyclophosphamide and dexamethasone.
2. Discussion
Sarcoidosis is an inﬂammatory disorder of unknown aetiology
characterised by the presence of non-caseating granulomas, with
no evidence of other known causes of granulomatous disease.
It involves multiple organs, most commonly the lungs, lymph nodes,
skin, and eyes, but may be present in any organ system. Involvement
of the musculoskeletal system is well described in the literature. Up
to 35% of patients will develop an acute or chronic polyarthropathy,
and skeletal muscle granulomas occur in 80% of patients, but are
largely asymptomatic. Skeletal lesions are typically bilateral and most
commonly seen in the small bones of the hand and feet with
associated skin lesions. Lesions of the axial skeleton and long bones
are considered uncommon, and occur in approximately 5% of
patients [2,3].
Large bone lesions may be painful or asymptomatic. Neither
skeletal surveys nor radio-isotope scans have proved reliable in
screening for skeletal lesions [4]. The lesions are typically small
cysts with minimal involvement of adjacent soft tissue, but may
present as an active lytic or sclerotic lesion or pathological
fracture. MRI features are of indistinct or well marginated lesions
of varying sizes with decreased intensity on T1 weighted images
and increased intensity on T2 and proton-density fat-saturated
weighted images, and lesions may enhance after contrast [5].
There are no pathognomonic features of skeletal sarcoidosis on
Fig. 1. Anteroposterior radiograph of pelvis at presentation.
Fig. 2. Lateral radiograph of right hip at presentation.
Fig. 3. STIR coronal MRI showing areas of signal abnormality in the right
femoral head.
Fig. 4. T2W sagittal MRI showing multiple areas of intermediate to high signal in
the right femoral head and pelvis.
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MRI, and the differential includes metastastatic disease, lymphoma,
myeloma and disseminated tuberculosis.
Treatment of skeletal sarcoidosis is largely symptomatic. Corticos-
teroids have not been shown to be effective. However spontaneous
resolution has been demonstrated on follow-up studies [3].
Moore et al., in a study of 40 patients with sarcoidosis and
musculoskeletal symptoms, found intramedullary bone lesions on
MRI in 43% of patients (17/40) [5]. The lesions ranged in size from
1 to 4 cm. Lesions of the large bones and axial skeleton were present
in 33% of patients (13/40), 9 of which were multiple and 4 solitary.
Two patients (5%) were coincidentally found to have MRI ﬁndings of
AVN of the hip, both of whomwere on corticosteroids. Less than half
of the patients had biopsies of the lesions, all of which demonstrated
non-caseating granulomas consistent with sarcoidosis.
The association between sarcoidosis and myeloma is poorly under-
stood. In a review of the literature, Sen et al. identiﬁed 11 reports
of patients with sarcoidosis who developed multiple myeloma [6].
The median interval from the time of diagnosis of sarcoidosis to that of
multiple myeloma was 6 years which was similar to the interval
of 5 years in our patient. They found that the median age at diagnosis
of sarcoidosis was 56 years which was signiﬁcantly older than that of
the general patient population with the disease. Sarcoidosis in older
age groups is associated with a chronic active clinical course. The pati-
ent in our case report was diagnosed with sarcoidosis at a more typical
age of 45 years.
In a review of the literature, Brincker found 145 patients with
sarcoidosis who had developed a malignant neoplasm, including
66 cases of various types of lymphoproliferative disorders [7,8].
The observed to expected ratio of lymphoid malignancies in
sarcoidosis patients was 13.2.
There is evidence that patients with sarcoidosis have immune
system dysregulation, including activation of CD4-positive T-helper
cells, increased secretion of cytokines, and decreased CD8-positive
T-suppressor cells [9,10]. The defective T-cell suppression and
increased cytokine secretion have been postulated to result in stimula-
tion of B cells. Hunninghake et al. showed that patients with
sarcoidosis have greater ratios of IgG and IgM secreting cells compared
to normal individuals [11]. They demonstrated that B lymphocytes in
normal individuals, when cultured with T lymphocytes from patients
with sarcoidosis, were induced to differentiate into immunoglobulin-
secreting cells. The extended half-life of B lymphocytes and plasma
cells in sarcoidosis patients may also increase their risk of undergoing
neoplastic transformation.
In a review on skeletal sarcoidosis, Moore et al. recommended
that in a patient with proven sarcoidosis, biopsy of musculoske-
letal lesions detected at MRI may not be necessary [12].
However, they added that in some patients in whom sarcoidosis
was not proven or a second comorbidity was suspected, a biopsy
should be undertaken. This leaves the clinician with a difﬁcult
management decision. Many patients with sarcoidosis will present
with anaemia and fatigue, either as a result of the primary disease or
as a side effect of treatment. MRI scans and possible subsequent
Fig. 6. A non-necrotising granuloma surrounded by a diffuse plasma cell inﬁltrate
(H&E, 100 magniﬁcation).
Fig. 7. A non-necrotising granuloma surrounded by a diffuse plasma cell inﬁltrate
(H&E, 400 magniﬁcation).
Fig. 8. Lambda light chain immunohistochemistry demonstrating diffuse positive
cytoplasmic staining.
Fig. 5. Anteroposterior radiograph at follow-up showing a lytic lesion in the
inferior neck of the right femur.
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biopsies in all patients with sarcoidosis and musculoskeletal com-
plaints would place a large strain on resources. We believe a high
index of suspicion and good clinical judgement is required when
patients with sarcoidosis present with musculoskeletal pain, and there
should be a low threshold for further investigation. Serum calcium,
total protein and albumin levels and possibly serum protein electro-
phoresis would assist in diagnosing or excluding multiple myeloma.
MRI is of limited value as it does not differentiate skeletal sarcoi-
dosis from myeloma, lymphoma, metastatic disease or disseminated
tuberculosis.
3. Conclusion
We describe a patient with sarcoidosis who subsequently
developed multiple myeloma to raise awareness of this associa-
tion. Eleven other cases have been reported in the literature. The
explanation for this association is not known, however immune
dysregulation may be involved in the pathogenesis. Orthopaedic
surgeons need to be aware of the association and the possibility of
dual pathologies to avoid missing the diagnosis of multiple
myeloma in patients with sarcoidosis. A high index of suspicion
and good clinical judgement is therefore required when patients
with sarcoidosis present with musculoskeletal pain, and there
should be a low threshold for further investigation.
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